Apple and Intel have reached a preliminary agreement on chip manufacturing, six years after Apple stopped using Intel processors for its Mac computers. This development suggests a strategic re-evaluation of chip sourcing for Apple and validation for Intel's efforts to expand its foundry services. Apple shares traded at $292.14 today, up 1.6 percent following the news.
Apple's initial pivot to its custom M-series chips for Macs aimed to enhance performance and integrate hardware and software more tightly. This new agreement, however, could indicate Apple's intent to diversify its supply chain for specific chip components or leverage Intel's manufacturing capabilities for future product lines. The scope of the agreement remains undisclosed, but any partnership would mark a notable change in Apple's historically insular chip strategy.
For Intel, securing any part of Apple's chip production would be a substantial win for its Intel Foundry Services division. CEO Pat Gelsinger has aggressively pursued external foundry customers to compete with industry leaders like TSMC. A deal with Apple would provide immediate credibility and a high-profile customer, potentially attracting other major clients to Intel's manufacturing plants. This move could accelerate Intel's path to reclaiming its leadership in chip fabrication.
Investors should view this agreement as a long-term catalyst for Intel's stock, particularly as its foundry business matures. A successful partnership with Apple could boost IFS revenue and improve market perception of Intel's manufacturing prowess. This validation could lead to a re-rating of Intel's valuation multiples, which currently reflect skepticism about its foundry ambitions. For Apple, the agreement could optimize production costs or secure critical supply for upcoming hardware initiatives, including its push into artificial intelligence and new device categories.
The market will closely watch for official statements from either Apple or Intel detailing the specific terms and scale of this preliminary agreement. Investors need clarity on the types of chips involved, whether it includes advanced packaging and the timeline for production ramp-up. Such details would provide a more concrete basis for re-evaluating both companies' equity outlooks and potential revenue impacts for Intel's foundry segment.
